Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Xiaobin Liu
University of Pennsylvania
Philadelphia, PA 19104
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
24
SSRN CITATIONS
0
CROSSREF CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
ACLY is the Novel Signaling Target of PIP
2
/PIP
3
and Lyn in Cancer
Number of pages: 30
Posted: 16 Jan 2020
Johnvesly Basappa
,
Mevlut Citir
,
Qian Zhang
,
Hong Y. Wang
, Xiaobin Liu,
Olga Melnikov
,
Hafiz Yahya
,
Frank Stein
,
Rainer Muller
,
Alexis Traynor-Kaplan
,
Carsten Schultz
,
Mariusz A. Wasik
and
Andrzej Ptasznik
Fox Chase Cancer Center, European Molecular Biology Laboratory (EMBL)- Germany, University of Pennsylvania, University of Pennsylvania, University of Pennsylvania, Fox Chase Cancer Center, Fox Chase Cancer Center, European Molecular Biology Laboratory (EMBL)- Germany, European Molecular Biology Laboratory (EMBL)- Germany, ATK Innovation, Analytics and Discovery, European Molecular Biology Laboratory (EMBL)- Germany - Cell Biology and Biophysics Unit, Fox Chase Cancer Center and Fox Chase Cancer Center
Downloads
24
(567,100)
View PDF
Download
Abstract:
Cancer, Metabolism, Src, Lyn, PI3K, ACLY, acetyl-CoA
Feedback
